AAAAAA

   
Results: 1-8 |
Results: 8
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GENOME ACTIVATION-INDUCED BY HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 TAX PROTEIN IS THROUGH COOPERATION OF NF-KAPPA-B AND TAT
Authors: CHENG H TARNOK J PARKS WP
Citation: H. Cheng et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GENOME ACTIVATION-INDUCED BY HUMAN T-CELL LEUKEMIA-VIRUS TYPE-1 TAX PROTEIN IS THROUGH COOPERATION OF NF-KAPPA-B AND TAT, Journal of virology, 72(8), 1998, pp. 6911-6916
HUMAN T-LYMPHOCYTE TRANSFORMATION WITH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-2
Authors: TARSIS SL YU MT PARKS ES PERSAUD D MUNOZ JL PARKS WP
Citation: Sl. Tarsis et al., HUMAN T-LYMPHOCYTE TRANSFORMATION WITH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-2, Journal of virology, 72(1), 1998, pp. 841-846
DANCIS,JOSEPH FESTSCHRIFT - INTRODUCTION
Authors: PARKS WP
Citation: Wp. Parks, DANCIS,JOSEPH FESTSCHRIFT - INTRODUCTION, The Journal of pediatrics, 132(3), 1998, pp. 1-1
CATALYTIC COMBUSTION FOR INDUSTRIAL GAS-TURBINES
Authors: ANSON D DECORSO M PARKS WP
Citation: D. Anson et al., CATALYTIC COMBUSTION FOR INDUSTRIAL GAS-TURBINES, International journal of energy research, 20(8), 1996, pp. 693-711
TIME-COURSE AND CYTOKINE DEPENDENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1 T-LYMPHOCYTE TRANSFORMATION AS REVEALED BY A MICROTITER INFECTIVITY ASSAY
Authors: PERSAUD D MUNOZ JL TARSIS SL PARKS ES PARKS WP
Citation: D. Persaud et al., TIME-COURSE AND CYTOKINE DEPENDENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1 T-LYMPHOCYTE TRANSFORMATION AS REVEALED BY A MICROTITER INFECTIVITY ASSAY, Journal of virology, 69(10), 1995, pp. 6297-6303
MODELING STUDIES APPLIED TO FUNCTIONALLY GRADED MATERIALS
Authors: MARKWORTH AJ RAMESH KS PARKS WP
Citation: Aj. Markworth et al., MODELING STUDIES APPLIED TO FUNCTIONALLY GRADED MATERIALS, Journal of Materials Science, 30(9), 1995, pp. 2183-2193
HUMAN T-CELLS TRANSFORMED IN-VITRO BY HUMAN T-CELL LYMPHOTROPIC VIRUS
Authors: TARSIS SL PARKS WP PARKS E PERSAUD D MUNOZ J
Citation: Sl. Tarsis et al., HUMAN T-CELLS TRANSFORMED IN-VITRO BY HUMAN T-CELL LYMPHOTROPIC VIRUS, Clinical research, 41(3), 1993, pp. 10000622-10000622
THE PHARMACOKINETICS AND SAFETY OF ZIDOVUDINE IN THE 3RD TRIMESTER OFPREGNANCY FOR WOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS AND THEIR INFANTS - PHASE-I ACQUIRED-IMMUNODEFICIENCY-SYNDROME CLINICAL-TRIALS GROUP-STUDY (PROTOCOL 082)
Authors: OSULLIVAN MJ BOYER PJJ SCOTT GB PARKS WP WELLER S BLUM MR BALSLEY J BRYSON YJ BOND B EFANTISPOTTER J GILLESPIE S GOURLEY J HELFGOTT A LAI S MITCHELL C OROURKE S PARKS W PERRYMARX D SCOTT W SETTLAGE R STIEHM R
Citation: Mj. Osullivan et al., THE PHARMACOKINETICS AND SAFETY OF ZIDOVUDINE IN THE 3RD TRIMESTER OFPREGNANCY FOR WOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS AND THEIR INFANTS - PHASE-I ACQUIRED-IMMUNODEFICIENCY-SYNDROME CLINICAL-TRIALS GROUP-STUDY (PROTOCOL 082), American journal of obstetrics and gynecology, 168(5), 1993, pp. 1510-1516
Risultati: 1-8 |